Veru receives patent allowance for enobosarm and semaglutide combo

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/18/2026

1. XENE
2. SPY
3. HUBS
4. NUE
5. RTB
6. ONON
7. AAPL
8. AZN
9. SPCX
10. TRMD

Go back to Veru receives patent allowance for enobosarm and semaglutide combo
(NASDAQ: VERU) Delayed: 2.42 +0.03 (1.26%)
Previous Close $2.39    52 Week High $ 
Open $2.39    52 Week Low $ 
Day High $2.44    P/E N/A 
Day Low $2.36    EPS $ 
Volume 65,435